The news is that they've 'accelerated' the timeline by pushing back commercialisation by a further 12 months.
That's assuming that the 18 month clinical phase which now appears to be 6 months doesn't also need adjustments further down the line.
No news would have been good news in this case I'm afraid.
Back in the bottom drawer for this one.
Ann: AGM Presentation, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
-0.005(0.89%) |
Mkt cap ! $61.48M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 55.5¢ | 55.5¢ | $6.449K | 11.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17070 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 190 | 1 |
View Market Depth
| Last trade - 10.09am 04/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |